Medications metabolism

All SSRIs (e.g., Feonard et ah, 1997) and in particular fluoxetine, Fluvosamine and paroxetine are metabolized by hepatic cytochrome P450 enzymes. Therefore, it is important to be aware of the possibility that the therapeutic or toxic effects of other medications metabolized by the cytochrome P450 isoenzyme system can be increased. Substantial inhibition of these isoenzymes converts a normal metabolizer into a slow metabolizer with regard to this specific pathway. Inhibition of the hepatic oxidative isoenzymes has been associated with a reduction, to a varying extent, in the clearance of many therapeutic agents, including the TCAs, several neuroleptics, antiarrhythmics, theophy-lene, terfenadine, benzodiazepines, carbamazepine, and warfarin (for a complete list, see Nemeroff et ak, 1996). 

Medications metabolized by the liver are secreted into bile. Bile enters the intestine and is eliminated in feces. Fat-soluble medications are reabsorbed from bile into the bloodstream and returned to the liver to be metabolized and eliminated by the kidneys. This process is called the enterohepatic cycle. Medications that are not metabolized by the liver are eliminated by the lungs at a rate that corresponds to the patient s respiration rate. These are volatile medications, such as anesthetics and medications that are metabolized to C02 and H20. Side effects such as rashes and skin reaction are commonly seen at sweat and salivary glands. For example, a patient may report tasting the medication. Medication excreted into saliva is eventually swallowed, reabsorbed, and... 

Each person carries his or her own genetic imprint for pain response and medication sensitivity. How this genetic profile is expressed may be significantly influenced by the environment. Studies of genetic polymorphisms linked to pain syndromes and medication metabolism promise a fresh therapeutic approach where targeted analgesia with fewer side effects may be possible based on genotype. 

As with erythromycin, drug interactions are extremely important with clarithromycin. Because clarithromycin inhibits the hepatic cytochrome P-450 system, it may result in increased levels of multiple medications metabolized by the liver [19]. Clarithromycin appeared to increase the mean steady-state plasma theophylline concentration and AUC from 15.6 p.g/ml and 249 pg hr/ml, respectively, in the absence of clarithromycin, to 18.4 pg/ml and 291 pg hr/ml in the presence of clarithromycin p< 0.001 for both concentration and AUC). Although a modest increase was seen in the plasma theophylline concentration, the concentration remained within the therapeutic range, and concurrent administration of clarithromycin and theophylline was safe and well tolerated [121]. Although the magnitude of elevation in theophylline was small, caution should be used when... 

Lorazepam (ahvan) Oral, IM, IV Anxiety disorders, preanesthetic medication Metabolized solely by conjugation 14 5 2-4... 

Injectable oxymorphone is not associated with CYP450 PK drug-drug interactions at clinically relevant doses. No dose adjustments required for concomitant medications metabolized via the CYP450 pathway. 

Method, There are two standard methods for the estimation of urea, (i) the hypobromite method, (ii) the urease method (p. 519). The chief merit of the hypobromite method is the rapidity of the analysis the results obtained are considered sufficiently accurate for most medical requirements, e.g., for the estimation of urea in urine. For accurate metabolic work, however, the urease method should be employed. 

Nitronaphthalene is metabolized to the carcinogenic 2-naphthylarnine in the human body (39). Respirators, protective clothing, proper engineering controls, and medical monitoring programs for workers involved in making by-product 2-nitronaphthalene should be used. 

The second method for mixture analysis is the use of specialized software together with spectral databases. We have developed a mixture analysis program AMIX for one- and multidimensional spectra. The most important present applications are the field of combinatorial chemistry and toxicity screening of medical preparations in the pharmaceutical industry. An important medical application is screening of newborn infants for inborn metabolic errors. 

The World Wide Web has transformed the way in which we obtain and analyze published information on proteins. What only a few years ago would take days or weeks and require the use of expensive computer workstations can now be achieved in a few minutes or hours using personal computers, both PCs and Macintosh, connected to the internet. The Web contains hundreds of sites of Interest to molecular biologists, many of which are listed in Pedro s BioMolecular Research Tools (http // www.fmi.ch/biology/research tools.html). Many sites provide free access to databases that make it very easy to obtain information on structurally related proteins, the amino acid sequences of homologous proteins, relevant literature references, medical information and metabolic pathways. This development has opened up new opportunities for even non-specialists to view and manipulate a structure of interest or to carry out amino-acid sequence comparisons, and one can now rapidly obtain an overview of a particular area of molecular biology. We shall here describe some Web sites that are of interest from a structural point of view. Updated links to these sites can be found in the Introduction to Protein Structure Web site (http // WWW.ProteinStructure.com/). 

A wealthy investor has come to yon for advice. She has been approached by a biochemist who seeks financial backing for a company that would market dinitrophenol and dicnmarol as weight-loss medications. The biochemist has explained to her that these agents are nnconplers and that they would dissipate metabolic energy as heat. The investor wants to know if yon think she should invest in the biochemist s company. How do yon respond ... 

Maintenance doses widely vary among patients (e.g., from 1 to 20 mg/day for warfarin), and are influenced by diet (variable vitamin K intake) and medications that affect coumarin metabolism (decreased drug clearance e.g., cotrimoxazole, amiodarone, erythromycin increased clearance e.g., barbiturates, carbamaze-pine, rifampin). Thus, regular monitoring is needed... 

A knowledge of the metabolic fate of a particular drug, both in terms of the identification and quantification of the metabolites, is necessary not only to ensure that its use will not cause more problems than the medical condition it is designed to alleviate but, from the drug company s perspective, to facilitate the design of more effective drugs. 

---